Researchers analyzed data on 39 weight-loss drugs taken by patients on antipsychotics for schizophrenia. Which one offered the best results?
Alternative to Meds Center has expanded its educational resources on Caplyta side effects. Whenever a newer medication ...
In contrast, one research trial using GLP-1 drugs on obese research subjects did not show a benefit from GLP-1 in the ...
Morning Overview on MSN
Regulators cleared the first non-antipsychotic drug for dementia-related agitation
Adults living with Alzheimer’s-related dementia now have a second FDA-approved drug for agitation, and for the first time, ...
In addition to my recent article on heat related illnesses and deaths, there are many medications that make one more prone to ...
A combination of THC and CBD eased symptoms in an especially frail population: patients with advanced dementia near the end ...
New therapies in the clinic for bipolar disorder hope to meet unmet needs of efficacy and minimal side effects.
For years, Alzheimer’s-related agitation had just one FDA-approved treatment, an antipsychotic. This spring, a ...
Serotonin syndrome (aka serotonin toxicity) is often misunderstood, causing both unnecessary worry and missed warning signs.
The Amazing Times on MSN
10 everyday medications you should never mix with your morning coffee (no matter what)
Ten common medications interact with coffee in ways that affect absorption, blood levels, and how well the drug works. The ...
As summer temperatures climb, so do the risks of heat-related illnesses, particularly for those who take certain medications, ...
A new study uses a novel PET radiotracer to uncover widespread M1 receptor deficits in living schizophrenia patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results